Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome
about
MicroRNAs and the resolution phase of inflammation in macrophagesIdentification of microRNAs regulating the developmental pathways of bone marrow derived mast cells.miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation.Plasma proteome changes associated with refractory cytopenia with multilineage dysplasiaTransfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups.Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients.The role of microRNAs in osteoclasts and osteoporosis.Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.The myelodysplastic syndrome as a prototypical epigenetic diseaseTranscriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease?Deregulation of microRNAs in myelodysplastic syndrome.Implication of microRNAs in the pathogenesis of MDS.Myelodysplastic syndrome hematopoietic stem cell.The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.Aberrant expression of microRNAs in bladder cancer.Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide.MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemiaThe role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification.Annotating Function to Differentially Expressed LincRNAs in Myelodysplastic Syndrome Using a Network-Based Method.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.Mechanisms of Impaired Neutrophil Migration by MicroRNAs in Myelodysplastic Syndromes.Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.Importance of miR-299-5p in colorectal cancer.Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia.Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related ChangesMicroRNA in Myelopoiesis and Myeloid Disorders
P2860
Q26821845-286EC2AC-7602-4038-9ECF-3EEA8817374AQ33646084-32987A5C-3B6D-4F9E-9D09-5A200A776179Q34190472-946B2658-2C57-49D2-B8D4-6A905C69DA2BQ34355585-86536024-3D13-420A-A287-EA31420425F0Q34648024-8210BE78-C47F-448A-A32B-05A34BBC1733Q35338994-B9ACFB0D-104E-4225-9F79-2608A0A0B549Q35785942-E68592C0-B46A-4505-BAFA-C3C93EEA725DQ36095679-E48AA91B-9DB0-4C54-AE43-90BE18A2ECAAQ36101445-9E731202-FEC8-4764-BB37-B4494E872169Q36190994-CE5B1155-68CC-45B1-8807-7B0E93A2BD5EQ36417421-DAF5EBA7-E6CD-499D-AADE-9D8F0753B255Q36833557-A15044AA-843C-4EEC-9164-C8DDB9DF167AQ36862388-1C7EB420-3102-4A85-A639-7294D94C0C05Q36962841-8CCB0DC1-BC6A-462D-B3C3-C72DFEA93B6BQ37352764-BD26F3AE-D89F-4018-8B30-47356013AA7AQ37919716-C9BD8038-7E91-46DD-91D2-3464491A715EQ38008748-0BA09126-3E0E-4843-9520-F5E80DD4E802Q38050694-7AF890AB-C2EF-4C29-8647-B09B97D7EFBCQ38061848-03AAD539-0264-4307-8028-4DC21CB80CC8Q38074249-47732D29-3227-4C2A-8DE7-2401327918D4Q38109811-278FA2E2-704A-4F2E-9B3E-C04C613A2B02Q38113961-B274C83E-240F-45C5-912C-F363DE48B42BQ38195796-4981A544-36AB-49CB-B140-F700AB732916Q38215614-BDDF51BD-560A-4F8B-B79F-EE90B7D89181Q38698438-FD56C82D-9DA2-4C04-A5A4-2505201245BFQ38804181-64272A00-88AC-4F19-9844-B7F1DEE2C010Q38880958-ABE2A300-E2B2-4F05-9985-62505E98DDADQ39167466-A16CB4FE-C7F4-42F3-96BD-9EE832D7A91FQ40355332-079FA675-F2D6-424E-8449-DD3F16148560Q41952325-17E13A0D-1CD2-4DBA-9D69-688F8F4C90E9Q42090518-C7C11A38-96E8-4CD3-BF7B-B3C6F0BE9B72Q49435928-6302B801-7377-4546-A5E1-406D9C12E105Q52803223-EB5F6D17-8103-4F47-9775-1D2E8C9054A9Q53423040-B11B463E-5B9B-4003-93F0-B73EB6A46352Q57157157-97CC9ECC-B56A-47BC-878B-64619F508B52Q57589030-D92CB44E-214A-4588-BC51-F35FBA8EA55A
P2860
Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@ast
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@en
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@nl
type
label
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@ast
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@en
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@nl
prefLabel
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@ast
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@en
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@nl
P2093
P2860
P356
P1476
Distinctive microRNA expressio ...... with myelodysplastic syndrome
@en
P2093
Alzbeta Vasikova
Jaroslav Cermak
Monika Belickova
Zdenek Krejcik
P2860
P2888
P304
P356
10.1038/EJHG.2010.209
P577
2010-12-08T00:00:00Z